<DOC>
	<DOCNO>NCT00002295</DOCNO>
	<brief_summary>To evaluate effect Isoprinosine patient diagnose AIDS relative : Laboratory ( immunologic defect ) : - Comparison total helper suppressor T-cell number among group . - Comparison change natural killer cell activity . - Comparison laboratory finding among group . Clinical change : - Comparison frequency opportunistic infection among group . - Comparison frequency development AIDS-related malignancy . - Comparison clinical manifestation relative severity time onset .</brief_summary>
	<brief_title>A Study Isoprinosine Patients With Severe AIDS</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Inosine Pranobex</mesh_term>
	<criteria>Exclusion Criteria Coexisting Condition : Patients history gout , urolithiasis , nephrolithiasis , renal dysfunction , severe gastric ulcer exclude . Concurrent Medication : Excluded : Steroids . Cytotoxic immunosuppressive agent . Radiotherapy . The follow exclude : Critically ill patient . Patients receive steroid , cytotoxic immunosuppressive agent , radiotherapy . Patients receive immunotherapy . Patients history gout , urolithiasis , nephrolithiasis , renal dysfunction , severe gastric ulcer . Prior Medication : Excluded : Any immunotherapy . Patients severe AIDS specify laboratory immunologic defect .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 1989</verification_date>
	<keyword>Infusions , Intravenous</keyword>
	<keyword>Drug Evaluation</keyword>
	<keyword>Administration , Oral</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Zidovudine</keyword>
	<keyword>Biological Availability</keyword>
</DOC>